Artal Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-100,000
| Closed | -$4.71M | – | 93 |
|
|
2019
Q2 | $4.71M | Sell |
100,000
-45,000
| -31% | -$2.12M | 0.19% | 70 |
|
|
2019
Q1 | $5.18M | Hold |
145,000
| – | – | 0.21% | 58 |
|
|
2018
Q4 | $4.14M | Buy |
145,000
+45,000
| +45% | +$1.29M | 0.15% | 49 |
|
|
2018
Q3 | $4.44M | Buy |
100,000
+50,000
| +100% | +$2.22M | 0.12% | 57 |
|
|
2018
Q2 | $2.94M | Buy |
50,000
+25,000
| +100% | +$1.47M | 0.06% | 63 |
|
|
2018
Q1 | $1.14M | Sell |
25,000
-25,000
| -50% | -$1.14M | 0.01% | 75 |
|
|
2017
Q4 | $1.17M | Buy |
+50,000
| New | +$1.17M | 0.02% | 73 |
|